Retinopathy News and Research

RSS

Improved method for predicting retinopathy of prematurity could reduce unnecessary tests

A multicenter group of 41 hospitals led by researchers at Children's Hospital of Philadelphia (CHOP) has confirmed that an improved method for predicting retinopathy of prematurity (ROP), a leading cause of blindness in children, was able to reduce the number of babies having invasive diagnostic examinations by nearly a third, while raising disease detection up to 100 percent.

14 Nov 2019

Artificial pancreas may improve glucose control in type 1 diabetics

A new study describes how patients could benefit from the use of newly available automatic closed-loop systems to administer insulin, popularly called “the artificial pancreas”.

30 Oct 2019

Retinal macular damage linked to sleep apnea in diabetes

A new Taiwanese study presented on October 14, 2019, at the Annual Meeting of the American Academy of Ophthalmology, reports that macular edema in diabetes occurs more often in those who have severe sleep apnea.

15 Oct 2019

AI detects over 95 percent of diabetic retinopathy cases

A new study presented at the Annual Meeting of the American Academy of Ophthalmologists (AAO) on October 14, 2019 reports an astonishing 95.% yield when artificial intelligence (AI) is used to screen a real life population for diabetic retinopathy.

15 Oct 2019

Ophthalmologists honored at AAO 2019 for exceptional service in medical and surgical eye care

The American Academy of Ophthalmology is honoring ophthalmologists who have improved eye care for millions worldwide through their commitment to their patients and their profession. The honorees will be recognized during AAO 2019, the 123rd Annual Meeting of the American Academy of Ophthalmology.

15 Oct 2019

Study: Automated AI screening system accurately detects diabetic retinopathy 95.5% of the time

New research shows that an automated, artificial intelligence (AI) screening system accurately detects diabetic retinopathy 95.5 percent of the time.

14 Oct 2019

Sleep apnea is a risk factor for developing diabetic macular edema, study shows

New research from Taiwan shows that severe sleep apnea is a risk factor for developing diabetic macular edema, a complication of diabetes that can cause vision loss or blindness. Diabetic macular edema was also more difficult to treat in patients with severe sleep apnea.

14 Oct 2019

WHO’S first world report on vision

Vision is the most compelling contributor to the quality of our senses, and yet eye care lags behind many other areas in the importance it commands in public health. The World Health Organization (WHO) has said, in its report timed for World Sight Day (October 10), that over 2.2 billion people around the world (out of a total of 7.7 billion) are blind, completely or partially.

9 Oct 2019

Researchers are developing new therapy to counter the effects of traumatic brain injury

A blow to the head or powerful shock wave on the battlefield can cause immediate, significant damage to a person's skull and the tissue beneath it.

4 Oct 2019

Inflammasome, Boehringer Ingelheim team up to develop new therapies for retinal diseases

Boehringer Ingelheim and Inflammasome Therapeutics Inc. (Inflammasome) today announced they have entered into a co-development and license agreement to develop up to three therapies for patients with retinal diseases.

From Boehringer Ingelheim International GmbH 25 Sep 2019

New study identifies potential enzyme target for diabetic retinopathy

A new study shows that diabetic retinopathy (DR), or retinal disease caused by the high blood glucose levels in diabetes mellitus, is due to the death of retinal cells because of the high levels of a pro-enzyme called lysyl oxidase propeptide (LOX-PP). This could help researchers develop specific treatments by targeting this molecule.

22 Sep 2019

Researchers discover potential approach to treating diabetic retinopathy

Boston University researchers have identified an enzymatic precursor that is toxic to retinal cells and could be used in new treatments for diabetic retinopathy.

20 Sep 2019

Researchers find potential new treatment for diabetic retinopathy

About one in three diabetic patients develops diabetic retinopathy (DR), which can impair vision and lead to blindness.

19 Sep 2019

Analysis of lens in the eye can predict patients with type 2 diabetes and prediabetes

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Barcelona, Spain (16-20 September) shows that specialist analysis of the lens in the eye can predict patients with type 2 diabetes and impaired glucose tolerance (IGT) (also known as prediabetes, a condition that often leads to full blown of type 2 diabetes).

16 Sep 2019

First genetic cause for a rare eye disease discovered

John A. Moran Eye Center physician-researcher Paul S. Bernstein, MD, PhD, and his patients at the University of Utah played a key role in the recent discovery of the first genetic cause for a rare eye disease.

11 Sep 2019

How much control is too much in type 1 diabetes?

Type 1 diabetes mellitus (T1DM) affects thousands of children, and causes high sugar levels because of low insulin production. In places with good access to medical care, blood glucose is first measured by capillary blood testing or continuous monitoring. Insulin is given as required by subcutaneous injection or insulin pump.

29 Aug 2019

Study shows how blood glucose levels affect risks in type 1 diabetes

A major new study on the association between blood glucose levels and risks of organ impairment in people with type 1 diabetes can make a vital contribution to diabetes care, in the researchers’ view.

28 Aug 2019

Asthma drug can inhibit changes in early stages of diabetic retinopathy

In a study published July 26 online in the journal Diabetes, physician-researchers from University Hospitals Rainbow Babies and Children's Hospital and Case Western Reserve University School of Medicine found that the asthma medication montelukast (brand name Singulair) can inhibit early changes in diabetic retinopathy, the eye disease which develops due to diabetes, in a mouse model of type 1 diabetes.

29 Jul 2019

HbA1c analyzer identifies diabetics with poor glycemic control and high risk of sight loss

This HbA1c analyzer is successfully supporting improved medical management of patients with sight-threatening diabetic retinopathy (STDR).

From EKF Diagnostics 16 Jul 2019

Smartphone-based telemedical DR screening could improve ophthalmic care

About one in ten people in southern India is diabetic. Around one in three suffers from a so-called diabetic retinopathy (DR), a disease of the retina caused by diabetes.

10 Jul 2019